Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

atoplab.com
 

Enter Stock Symbol:  

Regeneron Pharmaceuticals Inc. (REGN)

388.33 1.84 (0.48%)

09-18 16:00

Open:

382.73

Pre. Close:

386.49

High:

392.47

Low:

375.21

Volume:

606,032

Market Cap:

41918M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

393.031 - 395.232

395.232 - 397.246

Low:

369.496 - 372.328

372.328 - 374.921

Close:

384.148 - 388.332

388.332 - 392.163

Technical analysis  (as of: 2018-09-18 4:39:26 PM)

Overall:

      

Stoxline posted a SELL today, same as yesterday. This stock seems to continue bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 461.79     One year: 486.46

Support:

Support1: 361.19    Support2: 300.51

Resistance:

Resistance1: 395.37    Resistance2: 416.49

Pivot:

397.24

Moving Averages:

MA(5): 390.72     MA(20): 393.06

MA(100): 347.24     MA(250): 362.55

MACD:

MACD(12,26): 3.89     Signal(12,26,9): 6.08

%K %D:

%K(14,3): 32.56     %D(3): 39.31

RSI:

RSI(14): 50.27

52-Week:

High: 477  Low: 281.89  Change(%): -11.4

Average Vol(K):

3-Month: 73987  10-Days 50489

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
REGN has closed above bottom band by 19.7%. Bollinger Bands are 22.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2018-09-17T08:35:30-04:00
Your Daily Pharma Scoop: XBiotech Reports Positive Data, AstraZeneca's New Approval, Novartis' Positive MS Trial

Financial Analysis

Growth

NA

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

NA

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

NA

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology

Shares Out. (M)

108.06

Shares Float (M)

106.55

% Held by Insiders

% Held by Institutions

66.20

Shares Short (K)

3107

Shares Short Prior Month (K)

Stock Financials

EPS

16.460

EPS Est. Current Year

14.940

EPS Est. Next Year

16.370

EPS Est. Next Quarter

3.980

Forward EPS

20.923

Book Value (p.s.)

5.980

PEG Ratio

1.95

Profit Margin

26.90

Operating Margin

36.89

Return on Assets (ttm)

17.5

Return on Equity (ttm)

24.8

Qtrly Rev. Growth

9.4

Gross Profit (p.s.)

26.589

Sales Per Share

EBITDA (p.s.)

11.059

Qtrly Earnings Growth

42.20

Operating Cash Flow (M)

2000.00

Levered Free Cash Flow (M)

1400.00

Valuation

P/E

23.59

P/E Growth Ratio

P/BV

64.94

P/S

712240640.00

P/CF

20.98

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.